All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

WDNA ETF · WisdomTree BioRevolution Fund

The WDNA Exchange Traded Fund (ETF) is provided by WisdomTree. It is built to track an index: WisdomTree BioRevolution Index. The WDNA ETF provides physical exposure, so by buying it you actually own parts of all the 85 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofBioTech & Genomics1M perf.-13.41%
Last price
$17.66
1M perf.
-1.45%
1M flows
N/A
AuM
€2M
E/R
0.45%
Rating
Not rated
ESG Consensus®
esg grade icon
WDNA
$17.66

Performance & flows

Segment for quartile rank
December 31, 2025 → March 31, 2026
0-10-5051015%JANFEBMAR
Create a free account to view the flows graph
WDNA
$17.41
+2.97%
BioTech & Genomics
-10.31%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-1.45%
icon
+2.97%
icon
+42.00%
icon
+7.67%
icon
N/A
-5.14%
+2.97%
+2.97%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
CUSIP
97717Y618
ISIN
US97717Y6187
AuM
€2M
icon
E/R
0.45%
icon
Replication rating
Not rated
ESG Consensus®
esg grade icon
More details
NAV
3/31/2026
$17.41
1D NAV change
+4.20%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
85
Inception date
6/3/2021
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Benchmark
WisdomTree BioRevolution Index
Asset class
Factors
N/A
Investment strategy
The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
See all Trackinsight Enterprise features

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight Enterprise

Similar ETFs in your region

WDNA
1M perf.
-2.96%
E/R
0.45%
DOCG
1M perf.
-6.22%
E/R
0.49%
GNOM
1M perf.
-5.95%
E/R
0.5%
HTEC
1M perf.
-10.18%
E/R
0.8%
GNOG
1M perf.
-5.93%
E/R
0.5%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+2.97%
icon
+42.00%
icon
+7.67%
icon
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
80.64%
Switzerland
5.08%
Denmark
4.04%
United Kingdom
3.20%
Germany
1.57%
Bermuda
1.52%
Netherlands
1.34%
Japan
1.18%
Unavailable
0.16%
Other
1.28%
Sectors
Health Care
82.73%
Materials
3.45%
Consumer Staples
1.66%
Unavailable
11.17%
Other
1.00%
Diversification
Total weight of top 15 holdings out of 85
Top 15 holdings
Data as of February 28, 2026
MODERNA INC
JOHNSON&JOHNSON
US86366E1064
LILLY
STOKE THERAPEUTICS INC
NATERA
PFIZER
BIONTECH SE ADR
Create a free account to view top holdings
AMGEN-T
ASTRAZENECA
TWIST BIOSCIENCE CORP
IONIS PHARMACEUTICALS INC
UTD THERAPEUT
AMICUS THERAPEUTICS
BEAM THERAPEUTICS
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG

ESG Consensus® by Conser

Data as of December 31, 2025
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about WDNA ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


WDNA’s has a Final Sustainability Grade of either A+, A, or A-.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
89.66% of holdings have positive scoring
10.49% of holdings have negative scoring
14.34%
57.19%
18.13%
5.66%
Consensus levels
Strong
Medium
Weak
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

WisdomTree
WisdomTree ID Card
Number of funds
434
Total AuM
€130.53B
Expense ratio range
0.05% - 4.32%
Average expense ratio
0.5423%

Frequently asked questions about WDNA

What does WisdomTree BioRevolution Fund, WDNA, invest in?

WDNA is a Passive ETF. This ETF provides exposure to Other Developed markets Equities.

Which benchmark or index does WDNA replicate?

WDNA tracks the WisdomTree BioRevolution Index - USD, through a optimized sampling replication method.

What is the Total Expense ratio (TER) of WDNA?

WDNA carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.

When was WDNA launched?

WDNA was introduced to the market on June 3, 2021. It trades on United States

Who is the ETF issuer of WDNA?

WisdomTree BioRevolution Fund, WDNA, is provided by WisdomTree. Learn more about WisdomTree here.

What is the current assets under management (AUM) of WDNA?

WDNA oversees €2M in assets as of March 31, 2026.

How has WDNA performed lately?

Based on data from March 31, 2026, WDNA returned -1.45% over the past month, 2.97% over the last three months and 2.97% year-to-date.

What are the latest inflows or outflows for WDNA?

As of March 31, 2026, WDNA recorded net flows of -€301K year-to-date.

Does WDNA distribute dividends?

WDNA follows a distributing dividend policy, meaning it pays out income to investors. As of March 31, 2026, its 12-month trailing yield was 4.42%.

What are the main country or region exposures of WDNA?

As of February 28, 2026, WDNA has significant geographic allocations in USA, Switzerland and Denmark.

In which sector or theme does WDNA invest in?

As of February 28, 2026, WDNA focuses largely on Health Care, Materials and Consumer Staples.

How many securities does WDNA hold and how diversified is it?

As of February 28, 2026, WDNA holds 85 positions in its portfolio, with 38.19% of assets concentrated in its top 15 holdings.

What are the main positions in WDNA?

As of February 28, 2026, WDNA top three holdings include MODERNA INC, JOHNSON&JOHNSON and US86366E1064.

What is the base currency of WDNA?

The base currency of WDNA is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight